Titlebook: Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders; New Perspectives on Michael S. Ritsner,A. George Awad Book 2007 S

只看該作者 · 發(fā)表于 2025-3-24 15:58:55

Julio Bobes,M.-P. García-Portilla,Maria-Teresa Bascarán,Pilar-Alejandra Sáiz,Maria-Teresa Bobes-Bascics have replaced other drugs as the agents of choice in the treatment of anxiety and insomnia.. During this 25-year period a total of 13 benzodiazepine derivatives have been marketed in the United States. For this to occur a vast literature has accumulated reporting the preclinical and clinical tes

只看該作者 · 發(fā)表于 2025-3-24 21:24:48

只看該作者 · 發(fā)表于 2025-3-25 02:18:28

A. George Awad,Lakshmi N.P. Voruganticovered by phenotypic-based screening methods. However, identifying molecular targets for these bioactive compounds is a very laborious process. With the development and advancements in new methodologies and techniques for identification and biological analysis, various target identification methods

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 10:50
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved